There is endless profit potential to treat chronic diseases
I have noticed several articles describing how antibiotic development has bankrupted some pharmaceutical companies because there isn’t enough potential profit in a ten-day course to treat multi-resistant superbug infections.
Chronic disease treatments, on the other hand, appear to be extremely profitable. A single month’s treatment with the newer diabetes drugs, COPD inhalers, or blood thinners costs over $500, which means well over $50,000 over an effective ten year patent for each …
There is endless profit potential to treat chronic diseases
















![Finding peace and reclaiming humanity within a broken health care system [PODCAST]](https://kevinmd.com/wp-content/uploads/058307ba-bb36-43f1-9e3a-6e3100f183b5-190x100.jpeg)


![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)





